EMEnrica Marzani
Enrica Marzani
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Enrica Marzani has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Massimo Collino
Department of Neurosciences “Rita Levi Montalcini” University of Turin Turin Italy
3 shared publications - Chiara Rubeo
Department of Clinical and Biological Sciences, University of Turin, Corso Raffaello 30, 10125 Turin, Italy
2 shared publications - Eleonora Aimaretti
Department of Clinical and Biological Sciences, University of Turin, Corso Raffaello 30, 10125 Turin, Italy
2 shared publications Gustavo Ferreira Alves
Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin 10125, Italy
2 shared publicationsManuela Aragno
Department of Clinical and Biological Sciences, University of Turin, Turin 10125, Italy
2 shared publications- Alon Zemer
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 219
Food-relevant alkylated lysine derivatives cross the brain microvascular endothelium without evoking barrier leakage and gliosis
- 16 November 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 219
Open AccessFood-relevant alkylated lysine derivatives cross the brain microvascular endothelium without evoking barrier leakage and gliosis
- Open Access
- 3 April 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 198, 119274
Pharmacological inhibition of CDK9 counteracts neuroinflammatory impairments in sepsis-associated encephalopathy
- 3 April 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 198, 119274
Open AccessPharmacological inhibition of CDK9 counteracts neuroinflammatory impairments in sepsis-associated encephalopathy
- Open Access
- 29 July 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 178, 117191
Pharmacological inhibition of CK2 by silmitasertib mitigates sepsis-induced circulatory collapse, thus improving septic outcomes in mice
- 29 July 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 178, 117191
Open AccessPharmacological inhibition of CK2 by silmitasertib mitigates sepsis-induced circulatory collapse, thus improving septic outcomes in mice